R&D Systems™ Recombinant Human Endorepellin Protein

Catalog No.	Quantity
2364ER050	50 μg

Catalog No. 2364ER050 Supplier R&D Systems™ Supplier No. 2364ER050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its binding ability in a functional ELISA. When Recombinant Human VEGF R1/Flt-1 (Catalog # 321-FL ) is coated at 5μg/mL (100μL/well), the concentration of Recombinant Human Endorepellin/Perlecan that produces 50% of the optimal binding response is approximately 0.75-6μg/mL.

The Recombinant Human Endorepellin Protein is derived from NS0. The Recombinant Human Endorepellin Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 3339
• Molecular Weight (g/mol): 76.7 kDa
• Name: Endorepellin/Perlecan
• Quantity: 50 μg
• Source: Mouse myeloma cell line,NS0-derived human Endorepellin/Perlecan protein Arg3684-Ser4391 (Ser4004Thr),with a C-terminal 10-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: basement membrane-specific heparan sulfate proteoglycan core protein, endorepellin (domain V region), heparan sulfate proteoglycan 2, HSPG, perlecan, perlecan proteoglycan, PLCSchwartz-Jampel syndrome 1 (chondrodystrophic myotonia), PRCAN, SJA, SJS, SJS1
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.